A RETROSPECTIVE STUDY OF 25 PATIENTS WITH FOURNIER'S GANGRENE

Background: Fournier's gangrene is a rapidly progressing and life-threatening surgical emergency with high morbidity and mortality rates if not promptly diagnosed and treated. This study examines the outcomes of patients who were monitored and treated for Fournier's gangrene. We conducted a retrospe Methods: ctive study on 25 patients treated for Fournier's gangrene between February 2022 and February 2025. Diagnosis was clinical, based on genital, perineal, or perianal tenderness, induration, foul-smelling discharge, and subcutaneous crepitus. After hemodynamic stabilization, aggressive debridement was performed, with some cases requiring VAC therapy and repeat debridements as needed. This study included 25 patients: 2 (8%) females and 23 (92%) males, with a mean age of 55 ye Results: ars (range 35-75). The average hospital stay was 23.4 days, and the mean number of debridements was 2. Perianal abscesses were found in 15 (60%) patients, 21 (84%) had diabetes, 8 (32%) were HCV positive, and 20 (80%) were alcoholic. Escherichia coli was the most common organism (56%), though 78% had polymicrobial infections. All patients underwent extensive debridement; 12 (48%) required VAC therapy, which prolonged hospital stays. Colostomy was performed in 4 (16%) patients, and no deaths occurred. Conclusion: In Fournier's gangrene, early diagnosis, proper resuscitation, aggressive debridement, and VAC application in appropriate cases may help reduce morbidity, mortality, and the need for an ostomy.